P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.
about
The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomasType II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.Melanoma-associated mutants within the serine-rich domain of PAK5 direct kinase activity to mitogenic pathways.Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor).
P2860
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.
@en
type
label
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.
@en
prefLabel
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.
@en
P2093
P2860
P356
P1476
P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.
@en
P2093
Carl Morrison
Eugene S Kandel
Hannah Slabodkin
Mahamat Babagana
Sydney Johnson
Wiam Bshara
P2860
P304
P356
10.1002/MC.22611
P577
2017-02-23T00:00:00Z